# Dream Finders Homes, Inc.: financial statements, quarterly

DFH · NYSE · CIK 1825088 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dfh.md) · [Financials](/companies/dfh/financials.md) · [Filings](/companies/dfh/filings.md) · [Insiders](/companies/dfh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dfh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [896](/filings/0001825088-24-000066.md) | [1,138 d](/filings/0001628280-26-010837.md) | [828](/filings/0001825088-25-000031.md) | [1,056](/filings/0001825088-25-000054.md) | [1,006](/filings/0001628280-25-047455.md) | [1,560 d](/filings/0001628280-26-010837.md) | [990](/filings/0001628280-26-029073.md) | [1,151](/filings/0001628280-26-050969.md) | [970](/filings/0001628280-25-047455.md) | [1,213 d](/filings/0001628280-26-010837.md) | [888](/filings/0001628280-26-029073.md) | [1,063](/filings/0001628280-26-050969.md) |
| Cost of revenue | $m | [709](/filings/0001825088-23-000068.md) | [902 d](/filings/0001825088-24-000015.md) | [679](/filings/0001825088-24-000032.md) | [853](/filings/0001825088-24-000056.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [78.5](/filings/0001825088-24-000066.md) | [92.2 d](/filings/0001628280-26-010837.md) | [80.1](/filings/0001825088-25-000031.md) | [96.9](/filings/0001825088-25-000054.md) | [102](/filings/0001628280-25-047455.md) | [116 d](/filings/0001628280-26-010837.md) | [117](/filings/0001628280-26-029073.md) | [135](/filings/0001628280-26-050969.md) | [110](/filings/0001628280-25-047455.md) | [124 d](/filings/0001628280-26-010837.md) | [111](/filings/0001628280-26-029073.md) | [128](/filings/0001628280-26-050969.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [24.2](/filings/0001825088-24-000066.md) | [30.5 d](/filings/0001628280-26-010837.md) | [15.1](/filings/0001825088-25-000031.md) | [23.2](/filings/0001825088-25-000054.md) | [20.8](/filings/0001628280-25-047455.md) | [38.1 d](/filings/0001628280-26-010837.md) | [16.2](/filings/0001628280-26-029073.md) | [17.5](/filings/0001628280-26-050969.md) | [13.7](/filings/0001628280-25-047455.md) | [19.3 d](/filings/0001628280-26-010837.md) | [5.2](/filings/0001628280-26-029073.md) | [9.0](/filings/0001628280-26-050969.md) |
| Net income | $m | [76.1](/filings/0001825088-24-000066.md) | [102 d](/filings/0001628280-26-010837.md) | [54.5](/filings/0001825088-25-000031.md) | [80.9](/filings/0001825088-25-000054.md) | [70.7](/filings/0001628280-25-047455.md) | [129 d](/filings/0001628280-26-010837.md) | [54.9](/filings/0001628280-26-029073.md) | [56.6](/filings/0001628280-26-050969.md) | [47.0](/filings/0001628280-25-047455.md) | [58.7 d](/filings/0001628280-26-010837.md) | [13.3](/filings/0001628280-26-029073.md) | [27.7](/filings/0001628280-26-050969.md) |
| Diluted EPS | $ per share | [0.75](/filings/0001825088-24-000066.md) | not reported | [0.55](/filings/0001825088-25-000031.md) | [0.81](/filings/0001825088-25-000054.md) | [0.70](/filings/0001628280-25-047455.md) | not reported | [0.54](/filings/0001628280-26-029073.md) | [0.56](/filings/0001628280-26-050969.md) | [0.47](/filings/0001628280-25-047455.md) | not reported | [0.11](/filings/0001628280-26-029073.md) | [0.27](/filings/0001628280-26-050969.md) |
| Basic EPS | $ per share | [0.79](/filings/0001825088-24-000066.md) | not reported | [0.55](/filings/0001825088-25-000031.md) | [0.83](/filings/0001825088-25-000054.md) | [0.72](/filings/0001628280-25-047455.md) | not reported | [0.55](/filings/0001628280-26-029073.md) | [0.57](/filings/0001628280-26-050969.md) | [0.47](/filings/0001628280-25-047455.md) | not reported | [0.11](/filings/0001628280-26-029073.md) | [0.27](/filings/0001628280-26-050969.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [330](/filings/0001825088-24-000066.md) | [494](/filings/0001628280-26-010837.md) | [239](/filings/0001825088-25-000031.md) | [275](/filings/0001825088-25-000054.md) | [205](/filings/0001628280-25-047455.md) | [274](/filings/0001628280-26-010837.md) | [297](/filings/0001628280-26-029073.md) | [210](/filings/0001628280-26-050969.md) | [251](/filings/0001628280-25-047455.md) | [235](/filings/0001628280-26-050969.md) | [435](/filings/0001628280-26-029073.md) | [203](/filings/0001628280-26-050969.md) |
| Total assets | $m | [2,384](/filings/0001825088-23-000068.md) | [2,562](/filings/0001825088-25-000014.md) | [2,717](/filings/0001825088-24-000032.md) | [2,985](/filings/0001825088-24-000056.md) | [3,325](/filings/0001825088-24-000066.md) | [3,329](/filings/0001628280-26-010837.md) | [3,488](/filings/0001825088-25-000031.md) | [3,650](/filings/0001825088-25-000054.md) | [3,835](/filings/0001628280-25-047455.md) | [3,727](/filings/0001628280-26-050969.md) | [3,973](/filings/0001628280-26-029073.md) | [3,960](/filings/0001628280-26-050969.md) |
| Total liabilities | $m | [1,398](/filings/0001825088-23-000068.md) | [1,476](/filings/0001825088-25-000014.md) | [1,566](/filings/0001825088-24-000032.md) | [1,764](/filings/0001825088-24-000056.md) | [2,035](/filings/0001825088-24-000066.md) | [1,908](/filings/0001628280-26-010837.md) | [2,017](/filings/0001825088-25-000031.md) | [2,136](/filings/0001825088-25-000054.md) | [2,283](/filings/0001628280-25-047455.md) | [2,123](/filings/0001628280-26-050969.md) | [2,378](/filings/0001628280-26-029073.md) | [2,348](/filings/0001628280-26-050969.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [1,286](/filings/0001628280-26-010837.md) | not reported | not reported | [1,766](/filings/0001628280-25-047455.md) | [1,606](/filings/0001628280-26-050969.md) | [1,889](/filings/0001628280-26-029073.md) | [1,817](/filings/0001628280-26-050969.md) |
| Shareholders' equity | $m | [838](/filings/0001825088-24-000066.md) | [925](/filings/0001825088-25-000014.md) | [969](/filings/0001825088-24-000032.md) | [1,047](/filings/0001825088-24-000056.md) | [1,115](/filings/0001825088-24-000066.md) | [1,245](/filings/0001628280-26-010837.md) | [1,292](/filings/0001825088-25-000031.md) | [1,334](/filings/0001825088-25-000054.md) | [1,373](/filings/0001628280-25-047455.md) | [1,425](/filings/0001628280-26-050969.md) | [1,415](/filings/0001628280-26-029073.md) | [1,432](/filings/0001628280-26-050969.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [87.0 d](/filings/0001825088-24-000066.md) | [219 d](/filings/0001628280-26-010837.md) | [(248)](/filings/0001825088-25-000031.md) | [(111) d](/filings/0001825088-25-000054.md) | [(205) d](/filings/0001628280-25-047455.md) | [306 d](/filings/0001628280-26-010837.md) | [(44.7)](/filings/0001628280-26-029073.md) | [(68.5) d](/filings/0001628280-26-050969.md) | [(131) d](/filings/0001628280-25-047455.md) | [144 d](/filings/0001628280-26-010837.md) | [(49.5)](/filings/0001628280-26-029073.md) | [(102) d](/filings/0001628280-26-050969.md) |
| Capital expenditure | $m | [0.9 d](/filings/0001825088-24-000066.md) | [0.9 d](/filings/0001628280-26-010837.md) | [2.1](/filings/0001825088-25-000031.md) | [1.8 d](/filings/0001825088-25-000054.md) | [17.6 d](/filings/0001628280-25-047455.md) | [3.9 d](/filings/0001628280-26-010837.md) | [3.2](/filings/0001628280-26-029073.md) | [10.3 d](/filings/0001628280-26-050969.md) | [4.7 d](/filings/0001628280-25-047455.md) | [7.6 d](/filings/0001628280-26-010837.md) | [5.3](/filings/0001628280-26-029073.md) | [5.7 d](/filings/0001628280-26-050969.md) |
| Share repurchases | $m | [0.0 d](/filings/0001825088-24-000066.md) | [0.0 d](/filings/0001628280-26-010837.md) | [0.0](/filings/0001825088-25-000031.md) | [1.8 d](/filings/0001825088-25-000054.md) | [4.8 d](/filings/0001628280-25-047455.md) | [1.2 d](/filings/0001628280-26-010837.md) | [7.0](/filings/0001628280-26-029073.md) | [16.1 d](/filings/0001628280-26-050969.md) | [9.7 d](/filings/0001628280-25-047455.md) | [9.0 d](/filings/0001628280-26-010837.md) | [18.5](/filings/0001628280-26-029073.md) | [14.8 d](/filings/0001628280-26-050969.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [108](/filings/0001825088-23-000068.md) | [109](/filings/0001825088-24-000032.md) | [105](/filings/0001825088-24-000056.md) | [102](/filings/0001825088-24-000066.md) | [99.9](/filings/0001825088-25-000031.md) | [100](/filings/0001825088-25-000054.md) | [101](/filings/0001628280-25-047455.md) | [101](/filings/0001628280-26-029073.md) | [102](/filings/0001628280-26-050969.md) | [101](/filings/0001628280-25-047455.md) | [92.4](/filings/0001628280-26-029073.md) | [91.3](/filings/0001628280-26-050969.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.